AI Article Synopsis
- The study evaluates the effectiveness of the MASCC score versus procalcitonin (PCT) levels in predicting adverse outcomes for patients with febrile neutropenia (FN).
- PCT is shown to have a better prognostic capability than the MASCC score, indicating it could be a more reliable tool for risk stratification in FN cases.
- The findings suggest that using PCT alongside the MASCC score may enhance patient management and improve outcomes in this population.
Article Abstract
Background: Various risk-stratification scores have been developed to identify low-risk febrile neutropenia (FN). The Multinational Association of Supportive Care in Cancer (MASCC) score is a commonly used validated scoring system, although its performance varies due to its subjectivity. Biomarkers like procalcitonin (PCT) are being used in patients with FN to detect bacteremia and additional complications.
Objective: Our objective was to compare the performance of MASCC score with PCT in predicting adverse outcomes in patients with FN.
Methods: This was a prospective observational study that included chemotherapy-induced FN in hematologic or solid malignancy. The MASCC score, PCT levels, and blood cultures were taken at the first point of contact, and patient treatment was managed according to routine institutional protocol. The primary outcome was mortality at 30 days.
Results: A total of 100 patients were recruited, of which 92 had hematologic malignancy and 8 had solid malignancy. Forty-six patients were classified as low risk by MASCC score (≥21). The PCT threshold, 1.42 ng/mL, was taken as a cutoff value, with area under the receiver operating characteristic curve (AUROC) of 0.664 (95% confidence interval [CI] -0.55 to 0.77) for predicting mortality. AUROC for MASCC was 0.586 (95% CI 0.462 to 0.711).
Conclusions: PCT is a useful marker with better prognostic efficacy than MASCC score in patients with FN and can be used as an adjunct to the score in risk-stratifying patients with FN.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jemermed.2020.12.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Multinational Association for Supportive Care in cancer criteria. An Evaluation and recommendations for the management of neutropenia in the emergency department.
Int Emerg Nurs
November 2024
Department of Adult Health Nursing, Faculty of Nursing, The Hashemite University, P.O box 330127, Zarqa 13115, Jordan. Electronic address:
Objectives: We aimed to evaluate the reproducibility, accuracy, feasibility, and effect of the Multinational Association for Supportive Care in Cancer (MASCC) criteria on emergency clinical decisions, treatment, and health outcomes.
Methods: A retrospective cohort design was used.
Results: The MASCC score was better at correctly detecting the high urgency (70 % of patients with a high urgency were identified as high risk) than the low urgency (only 30 % of patients with a low urgency were identified as low risk).
Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia.
Acta Med Indones
July 2024
Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Article Synopsis
- Febrile neutropenia (FN) is a serious condition often seen in chemotherapy patients, with a notable mortality rate of 12.5%, making accurate risk assessment vital for effective treatment.
- This study, conducted at Cipto Mangunkusumo Hospital from 2015 to 2019, aimed to compare the effectiveness of two scoring systems—CISNE and MASCC—in predicting complications during hospitalization for FN patients.
- The results indicated that CISNE score outperformed MASCC in both solid and hematologic cancers, with significant differences in predictive accuracy, particularly highlighting CISNE's superior ability to forecast in-hospital complications.
The Effectiveness and Safety of Remdesivir Use in COVID-19 Patients with Neutropenia: A Retrospective Cohort Study.
Life (Basel)
October 2024
Department of Emergency Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.
Background: The COVID-19 pandemic poses severe risks for immunocompromised patients, especially those with neutropenia due to chemotherapy. This study evaluates the safety and effectiveness of remdesivir use in COVID-19 patients with neutropenia.
Methods: This retrospective study used the Chang Gung Research Database (CGRD) and extracted data from 98,763 patients with COVID-19 diagnosed between April 2021 and September 2022.
Survey of international pediatric nutritional supportive care practices: a report from the Pediatric Study Group of the Multinational Association of Supportive Care in Cancer (MASCC).
Support Care Cancer
September 2024
Division of Oncology, Children's Hospital of Philadelphia, 3500 Civic Center Boulevard, Philadelphia, PA, 19104, USA.
Purpose: Malnutrition is common in children with cancer. While multiple validated malnutrition screens exist, there is no universal, standardized approach to screen or diagnose malnutrition. The Multinational Association of Supportive Care in Cancer (MASCC) Pediatric Study Group is focused on oncologic supportive care for children and young adults.
View Article and Find Full Text PDFMucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity.
Support Care Cancer
August 2024
Department of Internal Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
Article Synopsis
- Haematology patients experiencing high-risk neutropenia are susceptible to bloodstream infections linked to mucosal barrier injuries, particularly during episodes of fever.
- A study involving 416 neutropenic haematology patients identified risk factors for these infections, noting that certain conditions like low MASCC scores and specific fungal colonizations significantly increased risk.
- Findings revealed that while low citrulline levels at fever onset correlated with candidaemia, they did not indicate the likelihood of bacterial infections; moreover, quinolone antibiotics appeared beneficial.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!